Literature DB >> 23722393

Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis.

Venu Talla1, Cui Yang, Gerry Shaw, Vittorio Porciatti, Rajeshwari D Koilkonda, John Guy.   

Abstract

PURPOSE: To determine if phosphorylated neurofilament heavy chain (pNF-H) released into the bloodstream and the pattern ERG are noninvasive indicators of neurodegeneration in experimental optic neuritis.
METHODS: Serum from Myelin oligodendrocyte glycoprotein (MOG)-specific T cell receptor-positive (TCR+) transgenic mice that develop isolated optic neuritis usually without any other characteristic lesions of inflammation or demyelination in the spinal cord and littermates negative for the transgene were assayed for the presence of serum phosphorylated neurofilament H (pNF-H). In vivo measurements of optic nerve and retinal ganglion cell injury were assessed by magnetic resonance imaging (MRI), optical coherence tomography (OCT), and pattern electroretinogram (PERG). Automated two dimensional fluorescence differential in-gel electrophoresis (2D-DIGE) of pooled optic nerve samples, light, and transmission electron micrographs were used to evaluate optic atrophy postmortem.
RESULTS: We found an almost 3-fold elevation in serum pNF-H levels in MOG+ mice relative to MOG-littermates (P = 0.02). 2D-DIGE revealed a 3-fold reduction in optic nerve neurofilaments. Visual function assessed by the PERG was reduced by one-quarter (P = 0.033) and latencies increased by 38% (P = 0.036). MOG+ mice with the lowest PERG amplitudes had optic nerve atrophy visualized by MRI. Optic nerve diameters were reduced by one-third (P = 0.0001) and axon counts reduced by more than two-thirds. Histopathology of the spinal cords was normal.
CONCLUSIONS: Elevated serum pNF-H levels and the PERG are useful markers of neurodegeneration of the optic nerve in isolated experimental optic neuritis. Our findings suggest that elevations of this axonal protein in patients with optic neuritis who had a poor visual outcome are likely also due to demise of optic nerve axons.

Entities:  

Keywords:  axonal degeneration; neurodegeneration; neurofilaments; neuroophthalmology; optic neuritis

Mesh:

Substances:

Year:  2013        PMID: 23722393      PMCID: PMC3700386          DOI: 10.1167/iovs.13-11899

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

Review 1.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.

Authors:  C Bjartmar; J R Wujek; B D Trapp
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

2.  Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.

Authors:  Yangtai Guan; Kenneth S Shindler; Philomela Tabuena; A M Rostami
Journal:  J Neuroimmunol       Date:  2006-07-07       Impact factor: 3.478

3.  Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.

Authors:  Muriel Hobom; Maria K Storch; Robert Weissert; Katharina Maier; Anand Radhakrishnan; Birgit Kramer; Mathias Bähr; Ricarda Diem
Journal:  Brain Pathol       Date:  2004-04       Impact factor: 6.508

4.  Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis.

Authors:  A Petzold; D Brassat; P Mas; K Rejdak; G Keir; G Giovannoni; E J Thompson; M Clanet
Journal:  Mult Scler       Date:  2004-06       Impact factor: 6.312

5.  A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.

Authors:  Kurt-Wolfram Sühs; Katharina Hein; Muriel B Sättler; Anke Görlitz; Christoph Ciupka; Kerstin Scholz; Barbara Käsmann-Kellner; Panagiotis Papanagiotou; Nina Schäffler; Cordula Restemeyer; Diana Bittersohl; Andrea Hassenstein; Berthold Seitz; Wolfgang Reith; Klaus Fassbender; Reinhard Hilgers; Christoph Heesen; Mathias Bähr; Ricarda Diem
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

6.  Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis.

Authors:  Gurumoorthy Krishnamoorthy; Amit Saxena; Lennart T Mars; Helena S Domingues; Reinhard Mentele; Avraham Ben-Nun; Hans Lassmann; Klaus Dornmair; Florian C Kurschus; Roland S Liblau; Hartmut Wekerle
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

7.  Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).

Authors:  V Lehmensiek; S D Süssmuth; J Brettschneider; G Tauscher; S Felk; F Gillardon; H Tumani
Journal:  J Neuroimmunol       Date:  2007-03-26       Impact factor: 3.478

8.  Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.

Authors:  C S Raine; U Traugott; R B Nussenblatt; S H Stone
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

9.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.

Authors:  S Anand Trip; Patricio G Schlottmann; Stephen J Jones; Daniel R Altmann; David F Garway-Heath; Alan J Thompson; Gordon T Plant; David H Miller
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

10.  Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.

Authors: 
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

View more
  8 in total

1.  Demonstration of reversible retinal ganglion cell dysfunction in inflammatory optic neuropathies utilizing pattern electroretinography.

Authors:  Austin Bach; Matthew D Kay
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

2.  Complex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAE.

Authors:  Venu Talla; Rajeshwari Koilkonda; Vittorio Porciatti; Vince Chiodo; Sanford L Boye; William W Hauswirth; John Guy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-22       Impact factor: 4.799

3.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

4.  Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.

Authors:  Venu Talla; Vittorio Porciatti; Vince Chiodo; Sanford L Boye; William W Hauswirth; John Guy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-11       Impact factor: 4.799

Review 5.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

6.  Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.

Authors:  Sheryl L Herrera; Vanessa L Palmer; Heather Whittaker; Blair Cardigan Smith; Annie Kim; Angela E Schellenberg; Jonathan D Thiessen; Richard Buist; Marc R Del Bigio; Melanie Martin
Journal:  Magn Reson Insights       Date:  2014-11-09

7.  Matrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis.

Authors:  Jian Kang; Shuqing Liu; Yifan Song; Yaojuan Chu; Mengru Wang; Yamin Shi; Fengyan Zhang; Lin Zhu
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

8.  Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.

Authors:  Gabrielle Frame; Adam Schuller; Matthew A Smith; Samuel D Crish; Christine M Dengler-Crish
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.